» Articles » PMID: 25371599

A Novel Rose Hip Preparation with Enhanced Anti-inflammatory and Chondroprotective Effects

Overview
Publisher Wiley
Specialties Biochemistry
Pathology
Date 2014 Nov 6
PMID 25371599
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Rose hip powder (RHP) alleviates osteoarthritis (OA) due to its anti-inflammatory and cartilage-protective properties. Substances contained in RHP might contribute to its clinical efficacy. The activity of two RHP (i.e., RH-A, from the whole fruit, RH-B, from fruits without seeds) was investigated in human peripheral blood leukocytes (PBL) and primary chondrocytes (NHAC-kn). RH-A and RH-B diminished the secretion of chemokines and cytokines in LPS/IFN-γ-activated PBL, including CCL5/RANTES, CXCL10/IP-10, interleukin- (IL-) 6, and IL-12. Most effects were transcriptional, since gene expression levels were significantly influenced by RH-A and RH-B. In IL-1β treated normal chondrocytes (NHAC-kn), both RH preparations reduced the expression of matrix metalloproteinase- (MMP-) 1, MMP-3, and MMP-13 and ADAMTS-4. These changes are associated with diminished inflammatory damage or cartilage erosion. Principal component analysis revealed that (1) RH-A and RH-B modified a large pattern of biomarkers, and (2) RH-B outperformed RH-A. Furthermore, RH-B contained more chondroprotective and anti-inflammatory constituents than RH-A. Thus, RHP contributed to restore cellular homeostasis in PBL and chondrocytes. RH preparations from fruits without seeds are thus expected to have an improved OA-preventive or OA-therapeutic profile, as subsequently shown in a related clinical trial.

Citing Articles

Optimization of betulinic and ursolic acids and phenolics extraction from endemic Rosa pisiformis using Box-Behnken design in relation to cytotoxic activities.

Demiray H, Dibek M, Ozel O Sci Rep. 2025; 15(1):1228.

PMID: 39774620 PMC: 11707180. DOI: 10.1038/s41598-024-80174-y.


Rosehip Extract Decreases Reactive Oxygen Species Production and Lipid Accumulation in Hypertrophic 3T3-L1 Adipocytes with the Modulation of Inflammatory State.

Kowalska K, Olejnik A Nutrients. 2024; 16(19).

PMID: 39408236 PMC: 11478984. DOI: 10.3390/nu16193269.


Unveiling the mechanisms for the development of rosehip-based dermatological products: an updated review.

Oarga Porumb D, Cornea-Cipcigan M, Cordea M Front Pharmacol. 2024; 15:1390419.

PMID: 38666029 PMC: 11043540. DOI: 10.3389/fphar.2024.1390419.


Medical treatment of osteoarthritis: botanical pharmacologic aspect.

Park J, Lee S J Rheum Dis. 2024; 31(2):68-78.

PMID: 38559799 PMC: 10973355. DOI: 10.4078/jrd.2023.0084.


Aromatic Plants as Potential Resources to Combat Osteoarthritis.

Maring M, Balaji C, Komala M, Nandi S, Latha S, Raghavendran H Comb Chem High Throughput Screen. 2023; 27(10):1434-1465.

PMID: 37861046 DOI: 10.2174/0113862073267213231004094629.


References
1.
Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier J, Fahmi H . Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2010; 7(1):33-42. DOI: 10.1038/nrrheum.2010.196. View

2.
Viji V, Helen A, Luxmi V . Betulinic acid inhibits endotoxin-stimulated phosphorylation cascade and pro-inflammatory prostaglandin E(2) production in human peripheral blood mononuclear cells. Br J Pharmacol. 2010; 162(6):1291-303. PMC: 3058162. DOI: 10.1111/j.1476-5381.2010.01112.x. View

3.
Martel-Pelletier J, Boileau C, Pelletier J, Roughley P . Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin Rheumatol. 2008; 22(2):351-84. DOI: 10.1016/j.berh.2008.02.001. View

4.
Goldring M, Berenbaum F . The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide. Clin Orthop Relat Res. 2004; (427 Suppl):S37-46. DOI: 10.1097/01.blo.0000144484.69656.e4. View

5.
Richard N, Porath D, Radspieler A, Schwager J . Effects of resveratrol, piceatannol, tri-acetoxystilbene, and genistein on the inflammatory response of human peripheral blood leukocytes. Mol Nutr Food Res. 2005; 49(5):431-42. DOI: 10.1002/mnfr.200400099. View